New bone graft material could improve spine surgery outcomes

NCT ID NCT06000319

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new material called Natural Matrix Protein (NMP) fibers, made from human bone, for spine fusion surgery. It includes 200 adults with degenerative disc disease, spinal stenosis, or spondylolisthesis who need fusion of up to three vertebrae in the neck or lower back. The goal is to see if NMP fibers help bones fuse safely and effectively, reducing the chance of repeat surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Natural Matrix Protein (NMP) fibers (human bone allograft)
What this could lead to
If successful, this could provide a safer, more effective way to fuse spine bones, reducing the need for repeat surgeries.
What could go wrong
This is an early-stage study with 200 participants, so results may not apply to everyone. Risks include bone resorption, inflammation, or ectopic bone formation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alabama Back Institute

    Jasper, Alabama, 35501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.